Differential recognition of Candida tropicalis, Candida guilliermondii, Candida krusei, and Candida auris by human innate immune cells
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: The deep-seated infections caused by the Candida genus are associated with a high mortality rate, and Candida albicans is the most frequent species associated with these diseases. The fungal wall is composed of macromolecules not synthesized by the host, and therefore is a source of ligands recognized by innate immune cells. Methods: We performed a comparative study analyzing the cell wall composition and organization of Candida tropicalis , Candida guilliermondii , Candida krusei , and Candida auri s, along with their ability to stimulate cytokine production and phagocytosis by human innate immune cells. Results: We found that the wall of these species had the basic components already described in C. albicans , with most of the chitin and b1,3-glucan located underneath the mannan layer. However, the walls of C. krusei and C. auris were rich in chitin and the former had a lower content of mannans. C. guilliermondii contained changes in the mannan and the b1,3-glucan levels. These species were differentially phagocytosed by human macrophages and stimulated cytokine production in a dectin-1-dependent pathway. C. krusei showed the most significant changes in the tested parameters, whereas C. auris behaved like C. albicans . Conclusion: Our results suggest that the cell wall and innate immune recognition of C. tropicalis , C. guilliermondii , C. krusei , and Candida auris is different from that reported for C. albicans . Keywords: cell wall, protein glycosylation, host–fungus interplay, phagocytosis, cytokine production
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“krusei the mortality rate is higher (20%–67%), likely related to their poor response to standard antifungal therapies.(6,8,9,11) Candida auris is an emergent fungal species, firstly identified in 2009 as an etiological agent of candidiasis, and has a natural resistance to several of the antifungal drugs used to treat…”
BackgroundHidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Evolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065
An integrated model of the recognition of Candida albicans by the innate immune system
Netea, M. G., Brown, G. D., Kullberg, B. J., & Gow, N. A. R. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1815 · Cited by 946 · cited 3×
“As it is composed of polysaccharides which are absent in the human cells, the cell wall is the main source of pathogen-associated molecular patterns that the immune system recognizes through pattern recognition receptors (PRRs), mainly localized at the cell surface of immune cells.(13,15) The C.”
BackgroundCandida albicans morphogenesis and host defence: discriminating invasion from colonization
Gow, N. A. R., van de Veerdonk, F. L., Brown, A. J. P., & Netea, M. G. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2711 · Cited by 888
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Importance of the Candida albicans cell wall during commensalism and infection
Gow, N. A., & Hube, B. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2012.04.005 · Cited by 347
Immune Recognition of Candida albicans β‐glucan by Dectin‐1
Gow, N. A. R., Netea, M. G., Munro, C. A., Ferwerda, G., Bates, S., Mora‐Montes, H. M., Walker, L., Jansen, T., Jacobs, L., Tsoni, V., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/523110 · Cited by 314
Self-citationMcKenzie, C. G. J., Koser, U., Lewis, L. E., Bain, J. M., Mora-Montes, H. M., Barker, R. N., Gow, N. A. R., & Erwig, L. P. (2010) · Infection and Immunity · doi:10.1128/iai.00001-10 · Cited by 250 · cited 1×
“albicans with macrophages.(63) The therapeutic strategies to control candidiasis are extremely limited when compared to the wide repertoire of drugs to treat bacterial infections, and this has negatively impacted the sensitivity of fungal cells to the currently available drugs.”
BackgroundSelf-citation
Cited by
Biofilm formation in medically important Candida species
Malinovská, Z., Čonková, E., & Váczi, P. (2023) · Journal of Fungi · doi:10.3390/jof9100955 · Cited by 167
Bruno, M., Kersten, S., Bain, J. M., Jaeger, M., Rosati, D., Kruppa, M. D., Lowman, D. W., Rice, P. J., Graves, B., Ma, Z., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0780-3 · Cited by 145
Horton, M. V., Johnson, C. J., Zarnowski, R., Andes, B. D., Schoen, T. J., Kernien, J. F., Lowman, D., Kruppa, M. D., Ma, Z., Williams, D. L., et al. (2021) · mSphere · doi:10.1128/msphere.00406-21 · Cited by 79
“mannans compared to O-linked mannans (20).”
Candida auris Phenotypic Heterogeneity Determines Pathogenicity In Vitro
Brown, J. L., Delaney, C., Short, B., Butcher, M. C., McKloud, E., Williams, C., Kean, R., & Ramage, G. (2020) · mSphere · doi:10.1128/msphere.00371-20 · Cited by 76
Mechanisms of pathogenicity for the emerging fungus Candida auris
Horton, M. V., Holt, A. M., & Nett, J. E. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011843 · Cited by 67
Allert, S., Schulz, D., Kämmer, P., Großmann, P., Wolf, T., Schäuble, S., Panagiotou, G., Brunke, S., & Hube, B. (2022) · Virulence · doi:10.1080/21505594.2022.2026037 · Cited by 66
Vila, T., Montelongo-Jauregui, D., Ahmed, H., Puthran, T., Sultan, A. S., & Jabra-Rizk, M. A. (2020) · mSphere · doi:10.1128/msphere.00760-20 · Cited by 58
Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression
Wang, D., An, N., Yang, Y., Yang, X., Fan, Y., & Feng, J. (2021) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-021-00890-2 · Cited by 52
Dickwella Widanage, M. C., Singh, K., Li, J., Yarava, J. R., Scott, F. J., Xu, Y., Gow, N. A. R., Mentink-Vigier, F., Wang, P., Lamoth, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61678-1 · Cited by 51
Weerasinghe, H., Simm, C., Djajawi, T. M., Tedja, I., Lo, T. L., Simpson, D. S., Shasha, D., Mizrahi, N., Olivier, F. A. B., Speir, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112522 · Cited by 47
Fayed, B., Jayakumar, M. N., & Soliman, S. S. M. (2021) · Medical Mycology · doi:10.1093/mmy/myab059 · Cited by 41
Innate immune response to Candida auris
Holt, A. M., & Nett, J. E. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102510 · Cited by 18
Metadata
- Authors
- Navarro-Arias, M. J., Hernández-Chávez, M. J., Garcia-Carnero, L. C., Amezcua-Hernández, D. G., Lozoya-Pérez, N. E., Estrada-Mata, E., Martínez-Duncker, I., Franco, B., & Mora-Montes, H. M.
- Venue
- Infection and Drug Resistance
- Publisher
- Informa UK Limited
- Published
- 2019-04
- Volume
- Volume 12
- Pages
- 783-794
- ISSN
- 1178-6973 (ISSN-L)
- OpenAlex
- W2926202803
- Cited by
- 134
- References
- 16
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.